BetterLife Pharma Inc. Files June 2025 6-K Report
Ticker: BETRF · Form: 6-K · Filed: Jun 23, 2025 · CIK: 1464165
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, regulatory-update
Related Tickers: BETRF
TL;DR
BetterLife Pharma (BETRF) filed its June 6-K, standard foreign issuer report. Nothing major disclosed.
AI Summary
BetterLife Pharma Inc. filed a Form 6-K on June 23, 2025, reporting for the month of June 2025. The company, formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc., is based in Vancouver, BC, and operates in the Pharmaceutical Preparations sector. This filing is a routine report for foreign private issuers.
Why It Matters
This filing provides an update on BetterLife Pharma Inc.'s regulatory reporting status as a foreign private issuer, which is important for investors tracking the company's compliance and disclosures.
Risk Assessment
Risk Level: low — This filing is a routine report and does not contain significant new financial or operational information that would immediately impact the company's risk profile.
Key Players & Entities
- BetterLife Pharma Inc. (company) — Registrant
- Pivot Pharmaceuticals Inc. (company) — Former Company Name
- Neurokine Pharmaceuticals Inc. (company) — Former Company Name
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers that is required to be filed with the SEC pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. It is used to report information that the issuer makes or is required to make public pursuant to the laws of its home country, or that it furnishes or is required to furnish to its security holders.
When was BetterLife Pharma Inc. formerly known as Pivot Pharmaceuticals Inc. and Neurokine Pharmaceuticals Inc.?
BetterLife Pharma Inc. was formerly known as Pivot Pharmaceuticals Inc. after a name change on April 17, 2015, and prior to that, it was known as Neurokine Pharmaceuticals Inc. after a name change on May 14, 2009.
What is BetterLife Pharma Inc.'s Standard Industrial Classification (SIC) code?
BetterLife Pharma Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Where is BetterLife Pharma Inc. headquartered?
BetterLife Pharma Inc. is headquartered at 1275 West 6th Avenue, Vancouver, BC V6H 1A6.
Does BetterLife Pharma Inc. file its annual reports under Form 20-F or Form 40-F?
BetterLife Pharma Inc. indicates that it files its annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 23, 2025 regarding BetterLife Pharma Inc. (BETRF).